← Back to Bills
HR 10175118th CongressFailed / ExpiredHouse

Global Alzheimer’s Initiative Now Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Aug 15, 2025
Latest Action Date
Nov 20, 2024

Latest Action

Referred to the House Committee on Foreign Affairs.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The Global Alzheimer’s Initiative Now Act (H.R. 10175) was a legislative proposal introduced in the 118th Congress aimed at addressing Alzheimer's disease on a global scale. The bill was referred to the House Committee on Foreign Affairs but did not advance further and ultimately failed or expired. Specific details about the bill's provisions, funding, or implementation mechanisms are not available in the provided source data.

Bottom Line

H.R. 10175 sought to establish a global initiative to combat Alzheimer's disease but did not progress beyond committee referral and expired without enactment.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House of Representatives during the 118th Congress.
  • It was referred to the House Committee on Foreign Affairs on November 20, 2024.
  • The bill's status is listed as failed or expired, indicating it did not become law.
Who Benefits?

["Individuals affected by Alzheimer's disease globally", 'Health organizations focused on neurodegenerative diseases', 'Government agencies involved in health and foreign affairs']

Potential Concerns

['Lack of publicly available full bill text limits understanding of specific policy measures and funding sources.', 'Unclear oversight and enforcement provisions due to missing detailed legislative language.', 'Potential challenges in international coordination and resource allocation given the global scope.']

Political Context

The bill was introduced during the 118th Congress and referred to the House Committee on Foreign Affairs, reflecting an interest in addressing Alzheimer's disease through international collaboration. However, it did not advance past committee referral and expired, indicating limited legislative momentum or prioritization within the congressional session.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

["Potential increased international collaboration on Alzheimer's research and treatment if similar initiatives are pursued in the future.", "Heightened awareness of Alzheimer's as a global health issue among policymakers and health organizations."]

GovScope Watchdog Notes

The absence of the bill's full text and official summary limits transparency and public understanding of the proposed legislative measures. Monitoring future related bills or initiatives is advisable to assess ongoing congressional efforts in global Alzheimer's disease policy.

Passage Likelihood: LowConfidence: 70%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready